ST ALBANS, United Kingdom–(BUSINESS WIRE)–SANTEN launches IKERVIS® – the first and only ciclosporin eye drops licensed in the UK, on 27th July 2015.
Electronic health records may improve financial returns, workflow efficiency
The use of electronic health records may result in significant financial returns and workflow efficiency for practices, according to a report.The prospective financial analysis evaluated data that affected cash flows relevant to the implementation of E…
Abbott reports $5.2 billion in second quarter worldwide sales
Abbott reported worldwide sales of $5.2 billion in the second quarter of 2015, a 10.8% increase on an operational basis and a 2.2% increase on a reported basis compared with the second quarter of 2014, according to a press release.Diluted earnings per …
Valeant announces Q2 revenue growth
Valeant Pharmaceuticals reported total revenue of $2.7 billion for the second quarter of 2015, a 34% increase over the same period a year before, according to a press release.“We once again exceeded our guidance and delivered our fourth consecutive quarter of greater than 15% organic growth,” J. Michael Pearson, chairman and CEO, said in the release. “[The results] were driven by outperformance in our U.S. businesses, strong results in certain emerging markets and outstanding starts to both the Salix and Dendron acquisitions. In addition, we have signed eight new transactions (Read more...)
Bevacizumab vs Ranibizumab for Macular Edema Due to BRVO
How does treatment between these two anti-VEGF agents compare in terms of visual acuity and central retinal thickness outcomes? The British Journal of Ophthalmology
VIDEO: Incorporating point-of-care testing into the ophthalmology practice
At the Kiawah Eye 2015 meeting, Charlene M. Grice, MD, discusses the benefits of point-of-care testing in the management of ocular surface disease.